Influenza B virus B/Utah/9/2014 antigen (MDCK cell derived, propiolactone inactivated)

DB11002ApprovedWithdrawnVaccines

A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection... Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the virus) which stimulates an immunological defence against future exposure to the virus, or "antigen".

First approval
United States, 2014
Also known as
influenza B virus B/Utah/9/2014 antigen

Resolves to

Clinical / RWD

What you can answer from here — as of June 30, 2026

6Clinical trialsPhase, status and sponsor resolved per trial
Sign in
8Marketed productsAcross 1 country and 3 labellers
Sign in

Which companies are running trials of Influenza B virus B/Utah/9/2014 antigen (MDCK cell derived, propiolactone inactivated), in which indications and phases, and which of those programs are still active?

Create a free account or log in to explore the full data card.

Create Account